Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis.
Tsang
W K
WK
Department of Medicine, Princess Margaret Hospital, Hong Kong, China.
Tong
K L
KL
Chan
H W
HW
D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006400:Hematocrit; D006801:Humans; D016030:Kidney Transplantation; D019808:Losartan / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011086:Polycythemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D019808:Losartan